1. Home
  2. FSEA vs IPSC Comparison

FSEA vs IPSC Comparison

Compare FSEA & IPSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FSEA
  • IPSC
  • Stock Information
  • Founded
  • FSEA 1890
  • IPSC 2019
  • Country
  • FSEA United States
  • IPSC United States
  • Employees
  • FSEA N/A
  • IPSC N/A
  • Industry
  • FSEA Savings Institutions
  • IPSC Medicinal Chemicals and Botanical Products
  • Sector
  • FSEA Finance
  • IPSC Health Care
  • Exchange
  • FSEA Nasdaq
  • IPSC Nasdaq
  • Market Cap
  • FSEA 51.2M
  • IPSC 58.1M
  • IPO Year
  • FSEA N/A
  • IPSC 2021
  • Fundamental
  • Price
  • FSEA $11.00
  • IPSC $0.54
  • Analyst Decision
  • FSEA
  • IPSC Strong Buy
  • Analyst Count
  • FSEA 0
  • IPSC 5
  • Target Price
  • FSEA N/A
  • IPSC $3.67
  • AVG Volume (30 Days)
  • FSEA 5.7K
  • IPSC 719.6K
  • Earning Date
  • FSEA 05-20-2025
  • IPSC 05-20-2025
  • Dividend Yield
  • FSEA N/A
  • IPSC N/A
  • EPS Growth
  • FSEA N/A
  • IPSC N/A
  • EPS
  • FSEA N/A
  • IPSC N/A
  • Revenue
  • FSEA $15,874,000.00
  • IPSC $6,589,000.00
  • Revenue This Year
  • FSEA N/A
  • IPSC $833.10
  • Revenue Next Year
  • FSEA N/A
  • IPSC N/A
  • P/E Ratio
  • FSEA N/A
  • IPSC N/A
  • Revenue Growth
  • FSEA 70.41
  • IPSC 194.81
  • 52 Week Low
  • FSEA $8.60
  • IPSC $0.34
  • 52 Week High
  • FSEA $11.69
  • IPSC $3.47
  • Technical
  • Relative Strength Index (RSI)
  • FSEA 47.43
  • IPSC 51.91
  • Support Level
  • FSEA $10.80
  • IPSC $0.52
  • Resistance Level
  • FSEA $11.24
  • IPSC $0.57
  • Average True Range (ATR)
  • FSEA 0.16
  • IPSC 0.03
  • MACD
  • FSEA 0.00
  • IPSC 0.00
  • Stochastic Oscillator
  • FSEA 42.55
  • IPSC 58.75

About FSEA First Seacoast Bancorp Inc.

First Seacoast Bancorp Inc is a savings and loan holding company. Its business consists of taking deposits from the general public and investing those deposits, together with funds generated from operations and borrowings from the Federal Home Loan Bank, in one-to-four-family residential real estate loans, commercial real estate, and multi-family real estate loans, acquisition, development and land loans, commercial and industrial loans, home equity loans and lines of credit and consumer loans. The company generates revenue from financial instruments, such as loans, letters of credit, and investment securities, as well as revenue related to mortgage servicing activities, and bank-owned life insurance.

About IPSC Century Therapeutics Inc.

Century Therapeutics Inc is a biotechnology company specializes in leveraging adult stem cells to develop advanced cell therapy products targeting cancer, autoimmune, and inflammatory diseases. Their innovative approach involves a genetically engineered allogeneic cell therapy platform comprising induced pluripotent stem cells (iPSCs), CRISPR-mediated precision gene editing, proprietary chimeric antigen receptors (CARs), Allo-EvasionTM technology, and cutting-edge manufacturing capabilities. This comprehensive platform aims to overcome the limitations of first-generation cell therapies by optimizing cell product performance, preventing rejection by the host immune system, and minimizing development and supply risks.

Share on Social Networks: